Supplementary Figure.2 Frequency distribution of 245 RILs for 10 traits (mean of three seasons)

Nov 20, 2014

50 likes | 115 Views

Supplementary Figure.2 Frequency distribution of 245 RILs for 10 traits (mean of three seasons). M35-1. B35. M35-1. B35. B35. M35-1. M35-1. B35. B35. M35-1. B35. M35-1. M35-1. B35. M35-1. B35. M35-1. B35. B35. M35-1.

Share Presentation

Embed Code

Link

seasons
supplementary figure
10 traits
245 rils
m35 1
2 frequency distribution

michael-warren

Download Presentation

Supplementary Figure.2 Frequency distribution of 245 RILs for 10 traits (mean of three seasons)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary Figure.2 Frequency distribution of 245 RILs for 10 traits (mean of three seasons) M35-1 B35 M35-1 B35
B35 M35-1 M35-1 B35
B35 M35-1 B35 M35-1
M35-1 B35 M35-1 B35
M35-1 B35 B35 M35-1

Supplementary figure 1A

Supplementary Figure 1: Comparison of the results obtained from three widely used databases (namely AmiGO, ArrayExpress and GeneCards ) with that from HypoxiaDB . A specific protein PGK1 is searched in HypoxiaDB and in the other databases. The results were compared.

167 views • 8 slides

Supplementary Figure 1.

Supplementary Figure 1. In-stent LL, mean (SD), mm. Baseline characteristics. No. of patients. Difference (95% CI). Control. Celecoxib. P int. Sex Male Female Age ≥65 years <65 years Diabetes Yes No LAD Yes No Type C lesion Yes No DES

80 views • 1 slides

Supplementary figure 2

Supplementary figure 2. +/+ +/m. kb. 12. 8. M +/+ +/m m/m. 2 kb 540bp 387bp. a. b. c. d. Supplementary figure 2. Generation of Unc5b mutant mice

216 views • 2 slides

Supplementary Figure 1

Supplementary Figure 1. A. B. Mean = 0 nm σ PSF = 72 nm. 200 nm. C. D. 200 nm. E. F. 1000 nm. Supplementary Figure 2. Supplementary Figure 3. A. B. Supplementary Figure 4. 1. 2. 3. 4. 5. Supplementary Figure 5. 1. 2. 3. 4. 5. 6. 7.

114 views • 5 slides

Supplementary Figure 2

Supplementary Figure 2. Supplementary Figure 2 . qRT -PCR-based analysis of LPA and LPC receptor expression in ARMs and ERMS cells lines. Panel A - LPAR1, LPAR2, and LPAR3 receptors. Panel B - G2A and GPR4 receptors. Combined data from two independent experiments are shown. A. B.

130 views • 1 slides

Supplementary Figure 2.

RCA. RVN. LCA. LVN. LCA. RVN. RJV. T. RJV. T. LVN. LJV. ARSA. E. LJV. TR. E. LSA. ARSA. TR. LSA. RCA. RSV. LSV. RSV. LSV. LBV. LBV. RL. LL. RL. LL. TD. H. H. Supplementary Figure 2.

77 views • 1 slides

Supplementary figure 2

Supplementary figure 2 PCA analysis of all the different cell lines used in the microarray experiments revealing three distinct sub groups ; translocation positive RMS cells (RMS, RMZ, RH3, RH40, RH41), translocation negative RMS cells (RD & RH18)and myoblasts (MYO & BIO).

136 views • 1 slides

Supplementary Figure 2:

Supplementary Figure 2: Enrichment of CNVs identified in this study in pericentromeric regions. The fusion that

86 views • 1 slides

Supplementary Figure 2

cd73 -/- +DSS Day 10. cd73 -/- + DSS Day 22. WT +DSS Day 10. WT +DSS Day 22. NF-  appaB p65 kDa. Supplementary Figure 2.

74 views • 1 slides

Supplementary Figure 2

Sigmoidal Fits, E02 Retinotopy. All fits have adjR 2 >0.95. 1.0. 1.0. 0.9. 0.9. 0.8. 0.8. 0.7. 0.7. 0.6. 0.6. 0.5. 0.5. 0.4. 0.4. 0.3. Normal Cortex. LPZ Center. 0.3. 0.2. 0.2. 0.1. 4. 4. 6. 6. 2. 2. -4. -4. -2. -2. 0. 0. -6. -6. 0 14 28 42

75 views • 1 slides

Supplementary Figure 10

splice acceptor consensus suggested by Schuler (2008). (in plants). GCAG/ G YAG/ G TTAG/ G TCAG/ T ACAG/ G ACAG/ A ACAG/ G ACAG/ T CCAG/ C. (in mammals). intron/exon border in rice epsps. Supplementary Figure 10

102 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. A B. PSA-Cre + /Pten +/+ PSA-Cre + /Pten loxP/loxP. Age ( wks ). 20 20 30 80. Weeks.

123 views • 1 slides

Supplementary Figure 2. Imputed frequency distributions of log-CRP values

Supplementary Figure 2. Imputed frequency distributions of log-CRP values among incident cases (dashed line) and controls (solid line) in NPHS-II, EAS and 25 published prospective studies. The heights of each distribution have been set as equal for visual clarity.

77 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. 14 days in culture. 21 days in culture. A. B. A. B. C. D. C. D. E. SF2.

61 views • 1 slides

Supplementary Figure 2

ND. ob/ob. Supplementary Figure 2. A. IL6. TNF α. IL1 β. IL10. CXCL10. CCL5. CCL2. IL6. TNF α. IL1 β. IL10. CXCL10. CCL5. CCL2. 12000. 2250. 12000. 150. 500. 5000. 15000. 35000. 2000. 10000. 10000. 120. 1750. 30000. 12500. 400. 4000. 8000. 1500. 8000. 25000.

100 views • 1 slides

Supplementary figure 2.

Guillemin et al. Supplementary figure 2. Supplementary figure 2 . Expression of BCL2L10 in human oocytes analyzed by immunofluorescence.

174 views • 3 slides

Supplementary Figure 2

A. HEK293. MRC-5. SKOV-3. MDAH-2774. Igfbp5 mRNA. Gapdh mRNA. anti-IGFBP-5. anti- b -actin. B. mock. IGFBP-5. mock. IGFBP-5. 2000. 1500. anti-CD31 (PECAM-1). tumor volume (mm 2 ). 1000. *. 500. 0. mock. IGFBP-5. 20. 15. number of blood vessels per tumor section. 10.

142 views • 2 slides

Supplementary Figure 2

Supplementary Figure 2. A. BWS. Number of Patients. 0 1 2 3 4 5 6 7 8 9 10 11 1213 1415 16 17 1819 20. death. 0 1 2 3 4 5 6 7 8 9 10 11 12 131415 1617 18 19 20 2122 23over. Years. B. AS. 25 20 15 10 5 0.

95 views • 2 slides

Supplementary Figure 2

A. *. B. *. *. *. Supplementary Figure 2.

55 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. Con. A. PELP1 Tg. Cyclin D1. B. Con. PELP1 Tg. Ser991 PELP1. Figure S2. Representative IHC images showing the status of cyclin D1 ( A ) and phos-PELP1 ( B )in the mammary glands of 6-month-old control and MMTV-rtTA-TetO-PELP1 bitransgenic mice.

207 views • 1 slides

Supplementary Figure 2

HCT116. HCT116. NT. SN. NT. SN38. 5. 1.6. LC3 labelling. 4. 1.2. SN38 IC50 (nM). 3. 0.8. LC3 spots/cell. LC3. 0.4. 2. HCT116. Actin. 0. 1. Clonogenic assay. SN38. siCT. siATG5. siATG7. 0. shLUC. shMAPK14. HCT116. NT. SN38. 3. LC3. Cytotoxic assay. 100. GAPDH.

98 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2.

53 views • 1 slides

More Related